Alfa Tech Cambridge Group has the talent to handle the complexities and schedule issues relating to Biotech and Pharmaceutical projects. We have successfully done numerous projects for large private companies, smaller start ups, and also public institutions in this sector.

Our ability to tap into our in-house MEP Design division's expertise with Biotech and Pharmaceutical projects gives us a unique advantage over our competition to manage the design, validate the costs, and manage the construction for this market. Since mechanical, electrical, and plumbing is often the majority of the cost of biotech and pharmaceutical projects, our ability to draw on our own designer's experience is invaluable to our clients.

Also, our Turnkey option is well suited to the demands of larger biotech or pharmaceutical projects. We are currently working in this model with several of our clients in this sector.

PDL BioPharma Corporate Headquarters
Redwood City, CA
$93 million
Center for Immunobiology & Vaccine Development
Oakland, CA
$5.8 million
Gilead Sciences Corporate Headquarters
Foster City, CA
Genetics, Development & Behavioral Sciences (Rock Hall)
San Francisco, CA
$90 million
Helen Diller Cancer Research Center
San Francisco, CA
$120 million
QB3 Institute
San Francisco, CA
$100 million
Center for Clinical Sciences Research
Stanford, CA
$60 million
Bayer Corporation South Properties Expansion
Berkeley, CA
$37 million
Children's Hospital Oakland Research Institute Lab Buildout
Oakland, CA
$16 million
XOMA Therapeutics Facility Renovations
Berkeley, CA